March 3, 2021
Business News

Oncodesign Announces a Share Ownership Plan for All Employees on the Occasion of the Group’s 25th Anniversary


DIJON, France–()–Regulatory News:

ONCODESIGN (Paris:ALONC) (ALONC – FR0011766229), a biopharmaceutical group specialized in precision medicine, is celebrating its 25th anniversary and announcing the launch of a new employee share ownership initiative. Carrying on from the capital increase subscribed for by the Executive Committee members in September, this transaction aims to foster engagement among the organization’s entire staff.

Establishment of the Oncodesign corporate mutual fund to support the PEE corporate savings plan

At its meeting on December 10, 2020, the Board of Directors, using the powers delegated by the Combined Shareholders’ Meeting of June 25, 2020 (15th resolution), decided on the main…



Click here to view the original article.

Related Posts

You might also like ...

TriMas Announces Departure of Josh Sherbin, Senior Vice President, General Counsel and Chief Compliance Officer
PAN Communications Selected by Healthcare Analytics Leader Definitive Healthcare to Drive Brand Visibility
Notice of Lead Plaintiff Deadline for Shareholders in the Velodyne Lidar, Inc. Class Action Lawsuit